Skip to main content

Catalyst Calendar

Mon, Aug 10, 2026

2 updates

2:30 AM

Innate Pharma to Advance Lacutamab Towards Phase 3 Following Partnership With Sobi and Appoints New Chief Medical Officer

innate-pharma.com

2:00 AM

Innate Pharma Enters Strategic Partnership With Sobi to License Lacutamab in T-cell Lymphoma

innate-pharma.com

Thu, Jul 23, 2026

1 updates

12:00 AM

Innate Pharma to Participate in a Bladder Cancer Panel at the BTIG Virtual Biotechnology Conference

innate-pharma.com

Tue, Jul 21, 2026

1 updates

12:00 AM

Innate Pharma Announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-drug Conjugate (ADC)

Enrollment • Phase 1innate-pharma.com

Fri, May 22, 2026

1 updates

12:00 AM

Outcome of Innate Pharma’s 2026 Annual General Meeting

innate-pharma.com

Tue, May 19, 2026

1 updates

12:00 AM

Innate Pharma to participate in the Jefferies Global Healthcare Conference

innate-pharma.com